A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer

OBJECTIVES: The Hedgehog pathway has been implicated in small cell lung cancer (SCLC) tumor initiation and progression. Pharmacologic blockade of the key Hedgehog regulator, Smoothened, may inhibit these processes. We performed a phase I study to determine the maximum tolerated dose (MTD) of sonideg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: Pietanza, M. Catherine, Litvak, Anya M., Varghese, Anna M., Krug, Lee M., Fleisher, Martin, Teitcher, Jerrold B., Holodny, Andrei I., Sima, Cami S., Woo, Kaitlin M., Ng, Kenneth K., Won, Helen H., Berger, Michael F., Kris, Mark G., Rudin, Charles M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427482/
https://ncbi.nlm.nih.gov/pubmed/27565909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.04.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados